UMCC 2013.051: Prospective Pilot Study Evaluating the Use of Cyclobenzaprine for Treatment of Sleep Disturbance, Fatigue, and Musculoskeletal Symptoms in Aromatase Inhibitor-treated Breast Cancer Patients

Trial Profile

UMCC 2013.051: Prospective Pilot Study Evaluating the Use of Cyclobenzaprine for Treatment of Sleep Disturbance, Fatigue, and Musculoskeletal Symptoms in Aromatase Inhibitor-treated Breast Cancer Patients

Discontinued
Phase of Trial: Phase II

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs Cyclobenzaprine (Primary)
  • Indications Sleep initiation and maintenance disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Nov 2014 Planned End Date changed from 1 Sep 2014 to 1 Dec 2014, according to ClinicalTrials.gov record.
    • 04 Jul 2014 New trial record
    • 19 May 2014 According to ClinicalTrials.gov record, status changed from recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top